MAPT and Alzheimer disease: Using 18F-THK5117, Ishiki et al. followed AD and age-matched healthy control patients up to 1.5 years and demonstrated yearly tau burden increases in temporal cortex and the fusiform gyrus, as well as widespread distribution throughout cortical regions compared to control patients.